Inquiry Basket
2'-Modified Nucleosides
(288/288) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(236/236) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(134/134) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
(288/288) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(236/236) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(134/134) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All
3',5'-O-DTBS-2'-O-TBDMS-N6-Bz-rA
Description: 3',5'-O-DTBS-2'-O-TBDMS-N6-Bz-rA is a modified adenosine nucleoside used in oligonucleotide synthesis. It features protective groups, including di-tert-butylsilyl (DTBS) at the 3' and 5' hydroxyl positions, tert-butyldimethylsilyl (TBDMS) at the 2' hydroxyl position, and a benzoyl (Bz) group at the N6 position of the adenine base. These modifications provide stability and protection during synthesis, ensuring precise and efficient assembly of oligonucleotides for various molecular biology and biotechnology applications.
CAT: BRP-01489
CAS: 401812-98-4
MF: C31H47N5O5Si2
MF: 625.91
Purity: ≥97%
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.19±0.1 g/cm3
Melting Point: 127-128 °C
InChIKey: KJCFCWKXNODZCR-WBMMKZCBSA-N
CanonicalSMILES: CC(C)(C)[Si]1(OCC2C(O1)C(C(O2)N3C=NC4=C(N=CN=C43)NC(=O)C5=CC=CC=C5)O[Si](C)(C)C(C)(C)C)C(C)(C)C
IUPAC Name: N-[9-[(4aR,6R,7R,7aR)-2,2-ditert-butyl-7-[tert-butyl(dimethyl)silyl]oxy-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl]purin-6-yl]benzamide
InChI: InChI=1S/C31H47N5O5Si2/c1-29(2,3)42(10,11)40-24-23-21(17-38-43(41-23,30(4,5)6)31(7,8)9)39-28(24)36-19-34-22-25(32-18-33-26(22)36)35-27(37)20-15-13-12-14-16-20/h12-16,18-19,21,23-24,28H,17H2,1-11H3,(H,32,33,35,37)/t21-,23-,24-,28-/m1/s1
Synonyms: Adenosine, N-benzoyl-3',5'-O-[bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-; 3',5'-O-Bis(t-butylsilyl)-2'-O-(t-butyldimethylsilyl)-N6-benzoyladenosine
3',5'-O-DTBS-2'-O-TBDMS-N2-ibu-rG
Description: 3',5'-O-DTBS-2'-O-TBDMS-N2-ibu-rG is a modified guanosine nucleoside used in oligonucleotide synthesis. It contains protective groups, including di-tert-butylsilyl (DTBS) at the 3' and 5' hydroxyl positions, tert-butyldimethylsilyl (TBDMS) at the 2' hydroxyl position, and an isobutyryl (ibu) group at the N2 position of the guanine base. These modifications ensure stability and protection during the synthesis process, allowing for precise and efficient assembly of oligonucleotides for various applications in molecular biology and biotechnology.
CAT: BRP-01490
CAS: 401813-00-1
MF: C28H49N5O6Si2
MF: 607.89
Purity: ≥97%
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.21±0.1 g/cm3
InChIKey: UCNRPVSECIYJFT-AGFSROSKSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C4C(O3)CO[Si](O4)(C(C)(C)C)C(C)(C)C)O[Si](C)(C)C(C)(C)C
IUPAC Name: N-[9-[(4aR,6R,7R,7aR)-2,2-ditert-butyl-7-[tert-butyl(dimethyl)silyl]oxy-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C28H49N5O6Si2/c1-16(2)22(34)31-25-30-21-18(23(35)32-25)29-15-33(21)24-20(38-40(12,13)26(3,4)5)19-17(37-24)14-36-41(39-19,27(6,7)8)28(9,10)11/h15-17,19-20,24H,14H2,1-13H3,(H2,30,31,32,34,35)/t17-,19-,20-,24-/m1/s1
Synonyms: Guanosine, 3',5'-O-[bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)-; 3',5'-O-DTBS-2'-O-TBDMS-N2-isobutyryl-Guanosine
3',5'-O-DTBS-2'-O-TBDMS-rA
Description: 3',5'-O-DTBS-2'-O-TBDMS-rA is a chemically modified adenosine nucleoside used in oligonucleotide synthesis. It is characterized by protective groups, including di-tert-butylsilyl (DTBS) groups at both the 3' and 5' hydroxyl positions, and a tert-butyldimethylsilyl (TBDMS) group at the 2' hydroxyl position of the ribose sugar. These modifications help protect the nucleoside during synthesis, ensuring stability and precision in the creation of oligonucleotides for various applications in molecular biology and biotechnology.
CAT: BRP-01491
CAS: 212375-93-4
MF: C24H43N5O4Si2
MF: 521.80
Purity: ≥97%
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.19±0.1 g/cm3
Melting Point: 191-193.4 °C
Boiling Point: 578.2±60.0 °C at 760 mmHg
InChIKey: NKVFXNVWNYNCJM-QTQZEZTPSA-N
CanonicalSMILES: CC(C)(C)[Si]1(OCC2C(O1)C(C(O2)N3C=NC4=C(N=CN=C43)N)O[Si](C)(C)C(C)(C)C)C(C)(C)C
IUPAC Name: 9-[(4aR,6R,7R,7aR)-2,2-ditert-butyl-7-[tert-butyl(dimethyl)silyl]oxy-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl]purin-6-amine
InChI: InChI=1S/C24H43N5O4Si2/c1-22(2,3)34(10,11)32-18-17-15(12-30-35(33-17,23(4,5)6)24(7,8)9)31-21(18)29-14-28-16-19(25)26-13-27-20(16)29/h13-15,17-18,21H,12H2,1-11H3,(H2,25,26,27)/t15-,17-,18-,21-/m1/s1
Synonyms: Adenosine, 3',5'-O-[bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-; 3',5'-O-Bis(t-butylsilyl)-2'-O-(t-butyldimethylsilyl)adenosine
3',5'-O-DTBS-2'-O-TBDMS-rC
Description: 3',5'-O-DTBS-2'-O-TBDMS-rC is a chemically modified cytidine nucleoside used in oligonucleotide synthesis. It features protective groups including di-tert-butylsilyl (DTBS) groups at both the 3' and 5' hydroxyl positions, and a tert-butyldimethylsilyl (TBDMS) group at the 2' hydroxyl position of the ribose sugar. These modifications ensure stability and protection during synthesis, facilitating the creation of high-quality, customized oligonucleotides for various applications in molecular biology and biotechnology.
CAT: BRP-01492
CAS: 438582-96-8
MF: C23H43N3O5Si2
MF: 497.78
Purity: ≥97%
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.13±0.1 g/cm3
Boiling Point: 519.6±60.0 °C at 760 mmHg
InChIKey: IAERLBNQNFRAMO-NXWXRZEISA-N
CanonicalSMILES: CC(C)(C)[Si]1(OCC2C(O1)C(C(O2)N3C=CC(=NC3=O)N)O[Si](C)(C)C(C)(C)C)C(C)(C)C
IUPAC Name: 1-[(4aR,6R,7R,7aR)-2,2-ditert-butyl-7-[tert-butyl(dimethyl)silyl]oxy-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl]-4-aminopyrimidin-2-one
InChI: InChI=1S/C23H43N3O5Si2/c1-21(2,3)32(10,11)30-18-17-15(29-19(18)26-13-12-16(24)25-20(26)27)14-28-33(31-17,22(4,5)6)23(7,8)9/h12-13,15,17-19H,14H2,1-11H3,(H2,24,25,27)/t15-,17-,18-,19-/m1/s1
Synonyms: Cytidine, 3',5'-O-[bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-; 3',5'-O-[Bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]cytidine
3',5'-O-DTBS-2'-O-TBDMS-rU
Description: 3',5'-O-DTBS-2'-O-TBDMS-rU is a chemically modified uridine nucleoside used in oligonucleotide synthesis. It is characterized by protective groups, including di-tert-butylsilyl (DTBS) groups at both the 3' and 5' hydroxyl positions, and a tert-butyldimethylsilyl (TBDMS) group at the 2' hydroxyl position of the ribose sugar. These modifications protect the nucleoside during synthesis, ensuring stability and precision in the creation of oligonucleotides for various applications in molecular biology and biotechnology.
CAT: BRP-01493
CAS: 212375-92-3
MF: C23H42N2O6Si2
MF: 498.76
Purity: ≥97%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.11±0.1 g/cm3
InChIKey: HWUBERHQHCSGOU-NXWXRZEISA-N
CanonicalSMILES: CC(C)(C)[Si]1(OCC2C(O1)C(C(O2)N3C=CC(=O)NC3=O)O[Si](C)(C)C(C)(C)C)C(C)(C)C
IUPAC Name: 1-[(4aR,6R,7R,7aR)-2,2-ditert-butyl-7-[tert-butyl(dimethyl)silyl]oxy-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C23H42N2O6Si2/c1-21(2,3)32(10,11)30-18-17-15(29-19(18)25-13-12-16(26)24-20(25)27)14-28-33(31-17,22(4,5)6)23(7,8)9/h12-13,15,17-19H,14H2,1-11H3,(H,24,26,27)/t15-,17-,18-,19-/m1/s1
Synonyms: Uridine, 3',5'-O-[bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-; 3',5'-O-[Bis(1,1-dimethylethyl)silylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]uridine
5-Ethynyluridine
Description: 5-Ethynyluridine is a modified uridine nucleoside featuring an ethynyl group (-C≡CH) attached to the fifth carbon atom of the uracil base. This modification provides unique properties such as enhanced base stacking interactions and increased stability of nucleic acid structures. It is commonly used in RNA labeling and detection applications, including RNA synthesis, site-specific modification, and click chemistry-mediated conjugation reactions for studying RNA dynamics and function in biological systems.
CAT: BRP-01494
CAS: 69075-42-9
MF: C11H12N2O6
MF: 268.22
Purity: ≥98%
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.67±0.1 g/cm3
Melting Point: 188-190 °C
InChIKey: QCWBIPKYTBFWHH-FDDDBJFASA-N
CanonicalSMILES: C#CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-ethynylpyrimidine-2,4-dione
InChI: InChI=1S/C11H12N2O6/c1-2-5-3-13(11(18)12-9(5)17)10-8(16)7(15)6(4-14)19-10/h1,3,6-8,10,14-16H,4H2,(H,12,17,18)/t6-,7-,8-,10-/m1/s1
Synonyms: 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-ethynylpyrimidine-2,4-(1H,3H)-dione; 5-Ethynyl uridine; 5-EU
N6-p-Sulfophenyladenosine sodium salt
Description: N6-p-Sulfophenyladenosine sodium salt is a modified adenosine derivative used extensively in biochemical and pharmacological research. Its unique modification at the N6 position allows for the detailed study of adenosine receptor interactions, signal transduction pathways, and the development of potential therapeutic agents targeting adenosine-related pathways. The addition of the sulfophenyl group can significantly influence its binding properties and biological activities, making it a valuable tool in various research applications.
CAT: BRP-01501
CAS: 1349749-05-8
MF: C16H16N5NaO7S
MF: 445.38
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
InChIKey: JYEFPEJJPNYEHO-KHXPSBENSA-M
CanonicalSMILES: C1=CC(=CC=C1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)S(=O)(=O)[O-].[Na+]
IUPAC Name: sodium;4-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]benzenesulfonate
InChI: InChI=1S/C16H17N5O7S.Na/c22-5-10-12(23)13(24)16(28-10)21-7-19-11-14(17-6-18-15(11)21)20-8-1-3-9(4-2-8)29(25,26)27;/h1-4,6-7,10,12-13,16,22-24H,5H2,(H,17,18,20)(H,25,26,27);/q;+1/p-1/t10-,12-,13-,16-;/m1./s1
Synonyms: Benzenesulfonic acid, 4-[(9-β-D-ribofuranosyl-9H-purin-6-yl)amino]-, sodium salt(1:1); N6-(p-Sulfophenyl)adenosine sodium salt; 4-[(9-β-D-Ribofuranosyl-9H-purin-6-yl)amino]benzenesulfonic acid sodium salt; N-(p-Sulfophenyl)adenosine sodium salt
Related CAS: 143668-15-9 (free acid)
6-Chlorouridine
Description: 6-Chlorouridine is a valuable modified nucleoside used in biochemical, pharmacological, and chemical biology research. Its chlorination at the 6-position allows scientists to study the effects of halogenation on nucleotide function, RNA structure, and potential therapeutic applications. This compound provides insights into the role of modified nucleosides in various biological processes and aids in the development of novel therapeutic agents and research tools.
CAT: BRP-01502
CAS: 255723-79-6
MF: C9H11ClN2O6
MF: 278.65
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.80±0.1 g/cm3
InChIKey: CYMWXTBIGHJEJG-YXZULKJRSA-N
CanonicalSMILES: C1=C(N(C(=O)NC1=O)C2C(C(C(O2)CO)O)O)Cl
IUPAC Name: 6-chloro-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11ClN2O6/c10-4-1-5(14)11-9(17)12(4)8-7(16)6(15)3(2-13)18-8/h1,3,6-8,13,15-16H,2H2,(H,11,14,17)/t3-,6-,7-,8-/m1/s1
Synonyms: 6-chloro-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Adenosine, monohydrochloride
Description: Adenosine monohydrochloride is a hydrochloride salt form of adenosine, a nucleoside composed of adenine and ribose. Adenosine plays a crucial role in biochemical processes such as energy transfer (e.g., ATP) and signal transduction as a neurotransmitter. In its monohydrochloride form, adenosine is more soluble in water, making it useful for various biochemical and pharmaceutical applications. This compound is employed in research focused on cellular metabolism, enzyme functions, and nucleic acid interactions. Additionally, adenosine monohydrochloride is used in studies investigating the effects of adenosine on cardiovascular and neurological functions.
CAT: BRP-01521
CAS: 19065-22-6
MF: C10H13N5O4.HCl
MF: 303.70
Purity: ≥98% by HPLC
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
InChIKey: YFJCRJZTDYDCRZ-MCDZGGTQSA-N
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.Cl
IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrochloride
InChI: InChI=1S/C10H13N5O4.ClH/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H/t4-,6-,7-,10-;/m1./s1
Synonyms: Adenosine hydrochloride; Adenosine hydrochloride (1:1); (2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hydrochloride; 9-β-D-Ribofuranosyl-9H-purin-6-amine monohydrochloride; 9-β-D-Ribofuranosyladenine monohydrochloride; D-Adenosine monohydrochloride; Adenine riboside monohydrochloride; β-D-Adenosine monohydrochloride; β-Adenosine monohydrochloride
Related CAS: 58-61-7 (free base) ; 58056-57-8 (x-hydrochloride )
Uridine, monohydrate
Description: Uridine hydrate is a hydrated form of uridine, a nucleoside consisting of uracil attached to a ribose sugar. Uridine is a key component of RNA and plays a significant role in cellular processes, including the synthesis of nucleic acids, glycoproteins, and cell membranes. Uridine hydrate is often used in biochemical and medical research to study RNA synthesis, metabolism, and the effects of nucleosides on cellular functions. It is also investigated for its potential therapeutic benefits in neurological disorders, liver function improvement, and cognitive enhancement. The hydrated form of uridine ensures better solubility and stability for various experimental and clinical applications.
CAT: BRP-01522
CAS: 128475-15-0
MF: C9H12N2O6.H2O
MF: 262.22
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
InChIKey: IDZICQNRCHBMKN-IAIGYFSYSA-N
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O.O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;hydrate
InChI: InChI=1S/C9H12N2O6.H2O/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16;/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16);1H2/t4-,6-,7-,8-;/m1./s1
Synonyms: Uridine, hydrate (1:1); Uridine hydrate; 1-β-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione hydrate; 1-β-D-Ribofuranosyluracil hydrate; β-Uridine hydrate
Related CAS: 58-96-8 (anhydrous) ; 921930-23-6 (dihydrate)
Guanosine, dihydrate
Description: Guanosine dihydrate is a hydrated form of guanosine, a nucleoside composed of the nitrogenous base guanine attached to a ribose sugar molecule, with two water molecules associated. Guanosine is an essential building block of RNA and plays critical roles in cellular metabolism and signaling. In research and biochemical applications, guanosine dihydrate is used to study RNA synthesis, structure, and function. It is also valuable in exploring nucleotide interactions, enzyme activity related to nucleic acids, and cellular energy transfer processes. The dihydrate form ensures better solubility and stability in aqueous solutions, facilitating its use in various experimental and therapeutic contexts.
CAT: BRP-01523
CAS: 6010-14-6
MF: C10H13N5O5.2H2O
MF: 319.27
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
InChIKey: HNZAKYGFPANILR-LGVAUZIVSA-N
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(NC2=O)N.O.O
IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;dihydrate
InChI: InChI=1S/C10H13N5O5.2H2O/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9;;/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19);2*1H2/t3-,5-,6-,9-;;/m1../s1
Synonyms: Guanosine, hydrate (1:2); Guanosine dihydrate; 2-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one dihydrate; 2-Amino-1,9-dihydro-9-β-D-ribofuranosyl-6H-purin-6-one dihydrate; Guanine ribonucleoside dihydrate; Vernine dihydrate
Related CAS: 118-00-3 (anhydrous) ; 1143525-19-2 (monohydrate)
Cytidine, monohydrochloride
Description: Cytidine monohydrochloride is the hydrochloride salt form of cytidine, a nucleoside consisting of cytosine attached to a ribose sugar. Cytidine is a crucial component of RNA, playing a vital role in cellular processes such as protein synthesis and cell signaling. In its monohydrochloride form, cytidine is more soluble in water, which enhances its applicability in biochemical and pharmaceutical research. This compound is used to study RNA synthesis, metabolism, and the regulatory mechanisms of nucleic acids. Additionally, cytidine monohydrochloride is investigated for its potential therapeutic benefits, including neuroprotection, cognitive enhancement, and treatment of certain genetic disorders. The increased solubility and stability of the monohydrochloride form make it suitable for various experimental and clinical applications.
CAT: BRP-01524
CAS: 7244-51-1
MF: C9H13N3O5.HCl
MF: 279.68
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Melting Point: 205-206.5 °C
InChIKey: KCURWTAZOZXKSJ-IAIGYFSYSA-N
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl
IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
InChI: InChI=1S/C9H13N3O5.ClH/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8;/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16);1H/t4-,6-,7-,8-;/m1./s1
Synonyms: Cytidine, hydrochloride (1:1); Cytosine, 1-β-D-ribofuranosyl-, monohydrochloride; Cytidine hydrochloride; 1-(β-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine hydrochloride; 1-β-D-Ribofuranosylcytosine hydrochloride; 4-Amino-1-β-D-ribofuranosyl-2(1H)-pyrimidinone hydrochloride; Cytosine riboside hydrochloride; β-D-Cytidine hydrochloride
Related CAS: 65-46-3 (free base)
3',5'-di-O-Benzoyl-2,2'-anhydro-L-uridine
Description: 3',5'-di-O-Benzoyl-2,2'-anhydro-L-uridine is a modified nucleoside derivative where uridine is chemically altered by the addition of benzoyl groups at the 3' and 5' positions and the formation of an anhydro bridge between the 2' positions of two ribose moieties. This modification impacts the nucleoside's structural and chemical properties, often used to study nucleoside behavior and interactions in biological systems. In research, this compound is utilized to investigate RNA synthesis, structure, and function, providing insights into nucleic acid chemistry and the effects of specific modifications on RNA activity. It is also valuable in developing nucleotide analogs for therapeutic and diagnostic purposes, exploring how such modifications can influence nucleic acid stability, binding affinity, and enzymatic processing. The benzoyl protection and anhydro linkage help enhance the molecule's stability and facilitate its use in various biochemical applications.
CAT: BRP-01525
CAS: 31615-96-0
MF: C23H18N2O7
MF: 434.40
Purity: ≥95% by HPLC
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.48±0.1 g/cm3
Boiling Point: 589.0±60.0 °C at 760 mmHg
InChIKey: WLLCZAIADALVGH-FFGOWVMKSA-N
CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C3C(O2)N4C=CC(=O)N=C4O3)OC(=O)C5=CC=CC=C5
IUPAC Name: [(2S,4S,5S,6R)-5-benzoyloxy-10-oxo-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-4-yl]methyl benzoate
InChI: InChI=1S/C23H18N2O7/c26-17-11-12-25-20-19(32-23(25)24-17)18(31-22(28)15-9-5-2-6-10-15)16(30-20)13-29-21(27)14-7-3-1-4-8-14/h1-12,16,18-20H,13H2/t16-,18-,19+,20-/m0/s1
Synonyms: 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 3-(benzoyloxy)-2-[(benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-, (2S,3S,3aR,9aS)-; (2S,3S,3aR,9aS)-3-(Benzoyloxy)-2-[(benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, dibenzoate (ester), stereoisomer; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 3-(benzoyloxy)-2-[(benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-, [2S-(2α,3β,3aβ,9aβ)]-; 3',5'-Di-O-benzoyl-O2,2'-anhydro-L-uridine
4'-C-Azido-2'-deoxy-2'-fluorocytidine
Description: 4'-C-Azido-2'-deoxy-2'-fluorocytidine is a modified nucleoside analog that has been studied for its potential antiviral properties. It belongs to a class of compounds that are designed to interfere with viral replication by targeting viral enzymes or RNA synthesis. The azido group (-N3) and fluorine substitution (-F) are modifications aimed at enhancing its activity or specificity against certain viruses.
CAT: BRP-01531
CAS: 1145869-35-7
MF: C9H11FN6O4
MF: 286.22
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
InChIKey: KTOLOIKYVCHRJW-JVZYCSMKSA-N
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)F
IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C9H11FN6O4/c10-5-6(18)9(3-17,14-15-12)20-7(5)16-2-1-4(11)13-8(16)19/h1-2,5-7,17-18H,3H2,(H2,11,13,19)/t5-,6+,7-,9-/m1/s1
Synonyms: Cytidine, 4'-C-azido-2'-deoxy-2'-fluoro-; 4'-C-azido-2'-deoxy-2'-fluoro-cytidine; 4-amino-1-((2R,3R,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
.gif)
2'-Fluoro-N2-dimethylformamidine-2'-deoxyguanosine
Description: 2'-Fluoro-N2-dimethylformamidine-2'-deoxyguanosine is a nucleoside analog that is modified to potentially inhibit viral replication. This compound typically incorporates a dimethylformamidine group (-N(CH3)2) at the N2 position of the guanine base and a fluorine substitution at the 2' position of the deoxyribose sugar. These modifications are often designed to enhance binding affinity or specificity for viral polymerases or reverse transcriptases, thereby interfering with viral nucleic acid synthesis.
CAT: BRP-01532
MF: C13H17FN6O4
MF: 340.32
Purity: ≥98% by HPLC
Appearance: White powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
InChIKey: KBFMHYOHKLKPFN-GRIPGOBMSA-N
CanonicalSMILES: CN(C)C=NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)F
IUPAC Name: N'-[9-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C13H17FN6O4/c1-19(2)4-16-13-17-10-8(11(23)18-13)15-5-20(10)12-7(14)9(22)6(3-21)24-12/h4-7,9,12,21-22H,3H2,1-2H3,(H,17,18,23)/t6-,7-,9-,12-/m1/s1
Synonyms: dmf-2'-F-dG; N2-Dimethylformamidine-2'-Fluoro-2'-Deoxyguanosine; N'-(9-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide; N2-dmf-2'-F-dG; 2'-F-dG(DMF)
.gif)
3'-O-TBDMS-2'-F-dC(Ac)
Description: 3'-O-TBDMS-2'-F-dC(Ac) is a modified nucleoside where an acetyl group is attached to the N4 position of the cytidine base, and the ribose sugar is protected with a t-butyl-dimethylsilyl group at the 3' hydroxyl. Additionally, fluorine is substituted at the 2' position of the ribose. These modifications are commonly utilized in scientific research and pharmaceutical development to alter the nucleoside's stability, specificity, or biological activity for various applications.
CAT: BRP-01533
MF: C17H28FN3O5Si
MF: 401.51
Purity: ≥98% by HPLC
Appearance: White to light yellow powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
InChIKey: VGWVGGIROFIQHX-NMFUWQPSSA-N
IUPAC Name: N-(1-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide
InChI: InChI=1S/C17H28FN3O5Si/c1-10(23)19-12-7-8-21(16(24)20-12)15-13(18)14(11(9-22)25-15)26-27(5,6)17(2,3)4/h7-8,11,13-15,22H,9H2,1-6H3,(H,19,20,23,24)/t11-,13-,14-,15-/m1/s1
Synonyms: N4-Acetyl-3'-O-(t-butyl-dimethylsilyl)-2'-fluoro-2'-deoxycytidine; N4-Ac-2'-F-3'-O-TBDMS-dC
3'-O-TBDMS-2'-F-dA(Bz)
Description: 3'-O-TBDMS-2'-F-dA(Bz) is a chemically modified nucleoside used in nucleic acid research and synthesis. This modification is employed to study nucleotide interactions, stability, and potential therapeutic applications by altering the chemical and biological properties of the nucleoside.
CAT: BRP-01534
CAS: 1244763-25-4
MF: C23H30FN5O4Si
MF: 487.61
Purity: ≥98% by HPLC
Appearance: White to light yellow powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
Density: 1.32±0.1 g/cm3
InChIKey: VTZHRUXQJMHXQW-RPLGYBLPSA-N
CanonicalSMILES: O=C(NC1=NC=NC2=C1N=CN2C3OC(CO)C(O[Si](C)(C)C(C)(C)C)C3F)C=4C=CC=CC4
IUPAC Name: N-(9-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
InChI: InChI=1S/C23H30FN5O4Si/c1-23(2,3)34(4,5)33-18-15(11-30)32-22(16(18)24)29-13-27-17-19(25-12-26-20(17)29)28-21(31)14-9-7-6-8-10-14/h6-10,12-13,15-16,18,22,30H,11H2,1-5H3,(H,25,26,28,31)/t15-,16-,18-,22-/m1/s1
Synonyms: Adenosine, N-benzoyl-2'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-fluoro-; N-Benzoyl-2'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-fluoroadenosine; N6-benzoyl-3'-O-(t-butyl-dimethylsilyl)-2'-fluorine-2'-deoxyadenosine; N-(9-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
3'-O-TBDMS-2'-F-dG(iBu)
Description: 3'-O-TBDMS-2'-F-dG(iBu) is a chemically modified nucleoside used in biochemical and pharmaceutical research. This compound is designed to alter the properties of guanosine for specific applications, such as enhancing stability, modifying base-pairing interactions, or studying enzymatic reactions involving guanine derivatives.
CAT: BRP-01535
CAS: 2382967-92-0
MF: C20H32FN5O5Si
MF: 469.59
Purity: ≥98% by HPLC
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
Density: 1.36±0.1 g/cm3
InChIKey: ACBLMVCONMEAIO-LZDVPDMXSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O[Si](C)(C)C(C)(C)C)F
IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-fluoro-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C20H32FN5O5Si/c1-10(2)16(28)24-19-23-15-13(17(29)25-19)22-9-26(15)18-12(21)14(11(8-27)30-18)31-32(6,7)20(3,4)5/h9-12,14,18,27H,8H2,1-7H3,(H2,23,24,25,28,29)/t11-,12-,14-,18-/m1/s1
Synonyms: 2'-F-3'-TBS-iBu-dG; N2-isobutyryl-3'-O-(t-butyl-dimethylsilyl)-2'-fluorine-2'-deoxyguanosine; Guanosine, 2'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-fluoro-N-(2-methyl-1-oxopropyl)-; N-(9-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
5'-O-DMT-N4-Acetyl-2'-fluoro-5-methyl-2'-deoxycytidine
Description: 5'-O-DMT-N4-acetyl-2'-Fluoro-5-methyl-2'-deoxycytidine is a chemically modified nucleoside used in the synthesis of oligonucleotides to enhance their stability, specificity, and resistance to enzymatic degradation, making it valuable for developing therapeutic agents, such as antisense oligonucleotides and siRNAs, and for studying nucleic acid interactions and enzymatic processes in research.
CAT: BRP-01541
MF: C33H34FN3O7
MF: 603.65
Purity: >98%
Appearance: White to light yellow powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
InChIKey: STUFCHVUNHNWMI-BUVRPPHQSA-N
IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]acetamide
InChI: InChI=1S/C33H34FN3O7/c1-20-18-37(32(40)36-30(20)35-21(2)38)31-28(34)29(39)27(44-31)19-43-33(22-8-6-5-7-9-22,23-10-14-25(41-3)15-11-23)24-12-16-26(42-4)17-13-24/h5-18,27-29,31,39H,19H2,1-4H3,(H,35,36,38,40)/t27-,28-,29-,31-/m1/s1
Synonyms: N-(1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide; 5'-O-DMT-N4-Acetyl-2'-Fluoro-5-methyl-2'-deoxycytidine; N4-Acetyl-5'-O-DMT-2'-fluoro-5-methyl-2'-deoxycytidine; N-Acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-5-methylcytidine; 5'-O-DMT-2'-F-5-Me-dC(Ac); N4-Acetyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine
N4-Acetyl-5-Iodo-2'-fluoro-2'-deoxycytidine
Description: N4-Acetyl-5-Iodo-2'-fluoro-2'-deoxycytidine is a chemically modified nucleoside used in oligonucleotide synthesis to enhance stability and resistance to enzymatic degradation due to its 2'-fluoro modification. The 5-iodo group allows for labeling and detection in various assays, while the N4-acetyl group protects the nucleobase during synthesis. This modified nucleoside is valuable for developing stable and specific therapeutic oligonucleotides, such as antisense oligonucleotides and siRNAs, and is also useful in research to study nucleic acid interactions and enzymatic processes.
CAT: BRP-01547
CAS: 2940869-29-2
MF: C11H13FIN3O5
MF: 413.14
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 2.19±0.1 g/cm3
InChIKey: KDMMJHWZVCPNLN-FDDDBJFASA-N
CanonicalSMILES: CC(=O)NC1=NC(=O)N(C=C1I)C2C(C(C(O2)CO)O)F
IUPAC Name: N-[1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-2-oxopyrimidin-4-yl]acetamide
InChI: InChI=1S/C11H13FIN3O5/c1-4(18)14-9-5(13)2-16(11(20)15-9)10-7(12)8(19)6(3-17)21-10/h2,6-8,10,17,19H,3H2,1H3,(H,14,15,18,20)/t6-,7-,8-,10-/m1/s1
Synonyms: N4-Ac-5-I-2'-F-dC; N4-Ac-5-iodo-2'-fluoro-2'-dC
